Publications by authors named "Susan Matesanz"

Claim this Profile
O
Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations.
Crystal M Proud, Elizabeth A Kichula, Susan E Matesanz, Ashutosh Kumar, Kayoko Saito

J Neuromuscul Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of delandistrogene moxeparvovec gene therapy: Motor outcomes and emerging safety concerns.
Dennis J Keselman, Juliana C Small, Tiffany Seneviratne, Sarah McCague, Taylor L Kaschak, Susan E Matesanz

Mol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence on nusinersen treatment of persons with SMA: a focused review.
Susan E Matesanz, Richard S Finkel

J Neuromuscul Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy.
Jodi M Wolff, Nora Capocci, Evrim Atas, Diana X Bharucha-Goebel, John F Brandsema, Susan E Matesanz

Neuromuscul Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current clinical applications of AAV-mediated gene therapy.
Barry J Byrne, Kevin M Flanigan, Susan E Matesanz, Richard S Finkel, Megan A Waldrop

Mol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feeding Difficulties and Respiratory Failure in a 14-Month-Old Girl.
Nina A Fainberg, Dennis Keselman, Susan E Matesanz, Kumaran Senthil

Pediatr Rev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia.
Anil R Wadhwani, Ashna Aggarwal, Steven Loscalzao, Megan L McSherry, Justin L Lockman, Susan Matesanz

Neurology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor function testing rates and outcomes in Duchenne muscular dystrophy with comorbid autism and attention-deficit/hyperactivity disorder.
Dennis Keselman, Allan Glanzman, Michael Y Thelen, Laura A Prosser, Jennifer McGuire, Susan E Matesanz

Neuromuscul Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy: A Call for Discussion.
Omer Abdul Hamid, D Micah Hester, Susan E Matesanz, Sarah Wright, Kaitlin Y Batley

Pediatr Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States.
Susan E Matesanz, Jonathan B Edelson, Katherine A Iacobellis, Erika Mejia, John F Brandsema

Neurol Clin Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preemptive dual therapy for children at risk for infantile-onset spinal muscular atrophy.
Susan E Matesanz, Karlla W Brigatti, Millie Young, Sabrina W Yum, Kevin A Strauss

Ann Clin Transl Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States.
Erika J Mejia, Kimberly Y Lin, Oluwatimilehin Okunowo, Katherine A Iacobellis, Susan E Matesanz

J Am Heart Assoc· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy.
Jeremy M Neese, Sabrina Yum, Susan Matesanz, Leslie J Raffini, Hilary B Whitworth

Neuromuscul Disord· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Experience With Gene Therapy in Older Patients With Spinal Muscular Atrophy.
Susan E Matesanz, Vanessa Battista, Jean Flickinger, Jennifer N Jones, Elizabeth A Kichula

Pediatr Neurol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Course in a Patient With Spinal Muscular Atrophy Type 0 Treated With Nusinersen and Onasemnogene Abeparvovec.
Susan E Matesanz, Candace Curry, Brianna Gross, Adam I Rubin, Rebecca Linn

J Child Neurol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Testing for Patients with Spinal Muscular Atrophy.
John F Brandsema, Brianna N Gross, Susan E Matesanz

Clin Lab Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Flaccid Myelitis: Characteristics and Outcomes of 2014 and 2016 Cases at a Single Center.
Susan Matesanz, Jennifer L McGuire, Sarah Hopkins

J Pediatr· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancement.
Susan Matesanz, Chelsea Kotch, Christopher Perrone, Angela J Waanders, Brook Hill

Neurol Neuroimmunol Neuroinflamm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis